Pharma Supplier Hub

Certara is a global, public life-science company providing biosimulation software, AI-driven modeling, and expert consulting across the entire drug development lifecycle. It supports discovery, preclinical, clinical, regulatory, and market access with predictive, evidence-based solutions that help optimize trial design, dosing, safety, and submissions. Buyers use Certara’s technology and services to accelerate development, de-risk portfolios, and demonstrate therapy value.

GenScript Biotech Corporation is a global life-science services and products provider specializing in gene synthesis, molecular biology reagents, and early drug discovery services. Its life-science services and products segment offers DNA/oligo synthesis, peptide and protein production, antibody development, and related research tools, supporting pharma, biotech, and academic discovery and preclinical projects worldwide.

o2h discovery, part of the o2h group, is a CRO offering integrated chemistry and biology services for early-stage drug discovery from sites in Cambridge, UK and Ahmedabad, India. With capabilities in medicinal chemistry, FBDD hit finding and hit-to-lead/lead optimisation, plus an innovation ecosystem spanning ventures, technology and co-working, it supports pharma and biotech partners from hit identification toward IP and IND-enabling milestones.

Protheragen’s Drug Ingredients and Chemicals division is an ISO 9001:2015–certified global supplier of APIs, excipients, intermediates, specialty chemicals, biomaterials and veterinary products, backed by extensive analytical and formulation capabilities. It offers API synthesis and contract manufacturing, impurity and stability testing, cosmetics safety analysis, and advanced novel drug delivery and nanoparticle/LNP solutions to support pharma, biotech and cosmetics R&D and procurement.

EKF Diagnostics is an AIM‑listed global diagnostics and biotechnology company headquartered near Cardiff, UK, with manufacturing in the USA and Germany. It offers point‑of‑care analyzers, central laboratory tests and media, and life sciences reagents and enzymes for healthcare, research and industrial applications across hematology, diabetes, connectivity, women’s health, sports, veterinary and bioprocessing.

ELGA LabWater, part of Veolia Water Technologies, provides laboratory water purification systems for research, analytical, clinical and healthcare labs. Its PURELAB and MEDICA ranges deliver purified and ultrapure water using integrated technologies like reverse osmosis, ion exchange, filtration and UV to support sensitive applications such as HPLC, PCR and diagnostics.

Elegen is a private synthetic DNA company founded in 2017 and headquartered in Menlo Park, California. The company supplies ENFINIA™ cell-free DNA synthesis products including Linear DNA and IVT Ready DNA for pharmaceutical R&D, biotech, and academic research applications.

ERS Genomics is a Dublin-based CRISPR/Cas9 IP licensing company founded in 2014 that provides global access to the foundational CVC patent portfolio. With 160+ licenses across 90+ countries, it serves biopharma, agriculture, and synthetic biology sectors through Standard, Express, and Early Access licensing programs.

SciNote ELN is a cloud-based electronic lab notebook and lab inventory platform designed for scientific and regulated labs. It centralizes projects, experiments, tasks, protocols, inventory, and results, with strong data security, 21 CFR Part 11 and GLP/GMP support, collaboration tools, mobile access, and integrations with protocols.io and Microsoft Office. Trusted by the FDA, USDA, and scientists in 100+ countries, it helps labs work faster, more accurately, and more compliantly.

Elemental Machines is a private LabOps connectivity and life sciences IoT company based in Cambridge, MA that unifies equipment, environmental, and workflow data into one platform. Its integrated hardware, software, and data science solutions enable continuous monitoring, contextual alerts, utilization analytics, and 21 CFR Part 11–compliant reporting for biopharma, R&D, manufacturing, academic, and government labs.

Elix is an AI drug discovery company offering Elix Discovery™, an all‑in‑one platform for predictive modeling, generative design, and physics‑based simulations tailored to medicinal chemists. The software supports training on in‑house and federated pharma data and is deployable on‑premise or in the cloud. PhD‑led consulting helps integrate the platform into existing drug discovery workflows.

Elixirgen Therapeutics is a Baltimore-based clinical-stage biotech developing gene and RNA therapies for rare and aging-associated diseases using its ZSCAN4 telomere-elongation and Bobcat® mRNA platforms. Lead programs include EXG-34217, an autologous ZSCAN4-modified CD34+ cell therapy for Telomere Biology Disorders in Phase I/II trials with FDA Orphan, Rare Pediatric Disease, and RMAT designations, and EXG-7001, a Bobcat® mRNA candidate encoding full-length dystrophin for Duchenne muscular dystrophy in pre

Elsevier is a global leader in scientific information, analytics and decision-support solutions for research and healthcare. It serves pharma and life science R&D teams with platforms like ScienceDirect, Scopus, Reaxys, Embase, LeapSpace for R&D and ClinicalKey, providing trusted content, curated data and AI-enabled tools that accelerate discovery, clinical development and patient care.

Emerson is a global industrial technology and automation company providing advanced systems, software and measurement solutions for essential industries, including life sciences. Its portfolio spans automation systems, discrete automation, final control, measurement instrumentation and test & measurement platforms, supported by a global service network.

Emulate is a Boston-based private biotech company providing Organ-Chip platforms and organ models that recreate human tissue and organ functions in vitro for more predictive drug discovery and safety testing. Its Human Emulation System, including a Liver-Chip accepted into the FDA’s ISTAND program, helps pharma and biotech teams generate human-relevant data and reduce reliance on animal studies.

Endometrics is a diagnostics company developing a unique, non-invasive menstrual-blood-based test for earlier detection of endometriosis using proprietary molecular biomarkers. The company’s mission is to deliver accessible, affordable diagnostics that advance health equity in women’s health, enabling at-home testing and supporting both clinical practice and research on endometriosis.

Cyclana Bio is a women’s health biotechnology company building a tissue-level drug discovery platform for endometriosis. Using menstrual fluid and extracellular matrix-focused assays, the team develops physiologically relevant models to stratify patients and identify novel drug targets aimed at curing endometriosis.

ENPICOM is a bioinformatics software engineering company offering a unified platform that integrates scalable data management, automated bioinformatics workflows, and AI/ML frameworks for biologics discovery and development. Its ENPICOM Platform enables lab and data scientists to run complex sequence analyses, deploy machine learning models, and streamline MLOps for antibody, vaccine, and broader biologics research.

Publicis Sapient is a global enterprise AI and digital transformation company that builds platforms like Bodhi, Slingshot and Sustain to modernize systems, orchestrate AI agents and automate IT operations. With deep industry context in health and other sectors, it helps large organizations move AI from pilots to secure production with faster delivery, cost savings and high accuracy.

Envision Pharma Group is a global, technology-enabled strategic solutions partner to pharmaceutical, biotech, and med‑tech companies, combining medical, commercial, and strategic expertise with AI-powered platforms. It delivers integrated services across the product lifecycle, including medical communications, strategic consulting, commercialization, market access, revenue management, compliance, and technology-enabled managed services.

DNA Script is a private biotechnology company that has pioneered enzymatic DNA synthesis and the SYNTAX benchtop DNA printing platform. SYNTAX and its reagent kits let labs synthesize up to 96 high‑quality ssDNA oligos overnight in‑house, giving pharma, biotech, CROs and core facilities greater speed, control and confidentiality in synthetic biology and genomics workflows.

Enzymit is an Israel-based synthetic biology company developing a proprietary computational enzyme design platform and cell-free bioproduction processes for novel biomolecular components and biochemicals. Its technology targets applications in biochemicals, food and beverages, personal care, and health and nutrition, delivering cheaper, efficient and sustainable enzyme-only manufacturing solutions.

EpicentRx is a clinical-stage biotech developing RRx-001, an NLRP3-inhibiting small molecule in Phase 3 for small cell lung cancer and severe oral mucositis, and AdAPT-001, a TGF-β-trap oncolytic adenovirus for refractory solid tumors. The portfolio targets cancer, inflammatory, neurodegenerative, and supportive care indications, supported by the proprietary eLoop IV delivery device.

Eppendorf is a global life science supplier that provides premium instruments, consumables, and services for liquid, cell, and sample handling workflows in research and industrial labs. Its portfolio spans pipettes, centrifuges, bioreactors, PCR devices, freezers, and plastics, supported by calibration and service tools like the Eppendorf Service Portal, making it a strategic partner for pharma and biotech procurement and R&D teams.